Monday, October 26, 2026 · Daily editionET --:--:--

Status not kept up to date

Robotic vs. Laparoscopic vs. Open Living Donor Hepatectomy

NCT06062706 · King Faisal Specialist Hospital & Research Center · Updated 2 Oct 2023

What is being tested
Donor hepatectomy
For
End Stage Liver Disease; Acute Liver Failure; Acute-On-Chronic Liver Failure; Hepatocellular Carcinoma
Kind of study
Watches patients without assigning a treatment. No drug phase (a device or procedure study).
Who can join
Ages 1 Month to 75 years. About 3,448 people. The full rules are on the registry page.
Where
Saudi Arabia
When
Starts or started 6 Aug 2023, ends 30 Oct 2023. Registered 2 Oct 2023.
Results
None posted yet.

In the researchers' words

This will be a study to examine the outcomes of open, laparoscopic, and robotic Living Donor Liver Transplantation (LDLT) procedures. The analysis will encompass 3,448 cases (1,724 donor-recipient pairs) from January 2011 to March 2023, documenting the transition between these surgical techniques, with a noted crossover in 2018.
ClinicalTrials.gov, NCT06062706

Sites

  • Organ Transplant Center of Excellence, King Faisal Specialist Hospital & Research CentreRiyadh, Saudi Arabia